Xconomy Health Tech
Pharma and software firms are actively embracing AI and machine learning, but governments may need to lead the way in accessing relevant data, says Molecular Health.
Molecular Health, a software firm focused on transforming big data into analysis and prediction tools for healthcare companies, believes biotech is in the early days of using artificial intelligence (AI) and machine learning in drug discovery and development.
It is not the technology available holding the industry back, but the managing and the monitoring of the data involved, according to Molecular Health CEO Friedrich von Bohlen.
“In certain parts of the process we can [embrace... Read more »